Pharmaceutical companies’ traditional medical education model relies on prominent researchers and publishers in the oncology space, otherwise known as Key Opinion Leaders (KOLs), to spread information about the newest therapies. There remain, however, significant untapped opportunities for oncology medical affairs to penetrate communities and reach more practitioners nationwide. Medical Science Liaisons that currently focus their […]
The post Untapped Opportunities for Oncology Medical Affairs Striving for better access and more equitable cancer care in communities nationwide appeared first on PharmaVOICE.
